ADA 2025 20 - 23 June 2025

CGM-based outcomes in adults with T2D receiving IcoSema vs comparators: post hoc analysis of COMBINE 1 and 3

Authors :

Concetta Irace¹; Vanja Cejvanovic²; Jonas Hughes Larsen³; Thaís M Pagliaro Rocha²; Yasuo Terauchi⁴; Chantal Mathieu⁵;

Affiliations

View Details Hide Details

{{ getPageNum(PDFPage) }}

Download poster (.pdf)

Keywords

Diabetes

Congress poster

Insulin

IcoSema (Icodec Semaglutide)

PHASE 3 (RCT)